Cancer clinical trials in the region Pays de la Loire
240 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Lymphoma
#NCT05463263
B cell lymphoma
T cell lymphoma
None
2
3 or more
Systemic Treatment-Naive
Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes)
Step Pharma, SAS
Phase 2
Liver and bile duct cancer
#NCT03727633
Hepatocellular carcinoma
Localized
Unhealthy
A
B
A
B
C
None
Systemic Treatment-Naive
Centre Hospitalier Universitaire Angers (Angers )
CHU de Montpellier
Phase 2
Lung cancer
#NCT05742607
NSCLC (Non-Small Cell Lung Cancer)
Localized
None
Systemic Treatment-Naive
ALK
EGFR
Immunotherapy
Targeted therapy
Centre Hospitalier Universitaire Angers (Angers )
Innate Pharma
Phase 1 / Phase 2
#NCT05118789
Locally Advanced
Metastatic
ROS-1
1
Systemic Treatment-Naive
Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes)
Nuvalent Inc.
Phase 1 / Phase 2
Endometrial cancer
#NCT04585750
#2023-504251-27-00
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
Bladder / Urinary Tract / Urethral cancer
#NCT04585750
#2023-504251-27-00
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
Lung cancer
#NCT04585750
#2023-504251-27-00
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
Pancreas cancer
Liver and bile duct cancer
Stomach and esophageal cancer
#NCT04585750
#2023-504251-27-00
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
Prostate cancer
#NCT04585750
#2023-504251-27-00
Metastatic Castration-resistant
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
PMV Pharmaceuticals, Inc
Phase 1 / Phase 2
Breast cancer
#NCT04585750
#2023-504251-27-00
Locally Advanced
Metastatic
TP53
1
2
3 or more
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
PMV Pharmaceuticals, Inc